Figure 3
Figure 3. Demonstrating the effect of dose escalation by dividing patients in to low and high OCT-1 activity groups and then further subdividing them on the basis of ADD received after 12 months.

Demonstrating the effect of dose escalation by dividing patients in to low and high OCT-1 activity groups and then further subdividing them on the basis of ADD received after 12 months.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal